A C+D investigation in July revealed that Boots and Lloydspharmacy told ministers last year that it was "too early" to press ahead with government plans to widen the use of hub-and-spoke dispensing.
The views and opinions discussed during this video news blog represent those of the speakers and not of Actavis UK Ltd Actavis
Adverse Event and Privacy Policy click here. Adverse events* should be reported.
Reporting forms and information can be found at http://www.mhra.gov.uk/yellowcard
Adverse events can also be reported to Actavis on 01271 385257
* ‘Patient safety is Actavis’ primary concern and we encourage healthcare professionals and patients to report any adverse event which may occur in relation to an Actavis product. An adverse event includes reports of any side effect, product misuse, abuse or overdose, including inappropriate use by children or women who are pregnant or breast-feeding. It also includes reports of a product that was used for something other than the intended purpose or was ineffective, or was given with another medicine. Complaints relating to the product can also be reported.’
